Home Nucleus Medical Devices U.K. Breast Cancer Diagnostics Market to 2032

U.K. Breast Cancer Diagnostics Market to 2032

Overview

The U.K. Breast Cancer Diagnostics Market is expected to reach a 198.12 USD Million by 2032 and is projected to grow at a CAGR of 11.58% from 2025 to 2032.

Revenue, 2024 (USD Million)
99.29
Forecast, 2032 (USD Million)
198.12
CAGR, 2024 - 2032
11.58%
Report Coverage
U.K.

U.K. Breast Cancer Diagnostics Market 2018-2032 USD Million

U.K. Breast Cancer Diagnostics Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 99.29 USD Million
  • Projected Market Size (2032): 198.12 USD Million
  • CAGR (2025-2032): 11.58%

Key Findings of U.K. Breast Cancer Diagnostics Market

  • The U.K. Breast Cancer Diagnostics Market was valued at 99.29 USD Million in 2024.
  • The U.K. Breast Cancer Diagnostics Market is likely to grow at a CAGR of 11.58% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Invasive Ductal Carcinoma in Type Segment accounted for the largest share of the market with a revenue of 68.03 USD Million
  • The fastest growing segment Hospitals in End User Segment grew Fastest with a CAGR of 13.17% during the forecast period from 2024 to 2032.

U.K. Breast Cancer Diagnostics Market Scope

U.K. Breast Cancer Diagnostics Market Segmentation & Scope
Test
  • Others
  • Blood Test
  • Genomic Test
  • Biopsy
  • Imaging
Type
  • Metastatic Breast Cancer
  • Inflammatory Breast Cancer
  • Ductal Carcinoma In Situ
  • Invasive Ductal Carcinoma
End User
  • Others
  • Research & Academic Institutes
  • Clinics
  • Diagnostic Centers
  • Hospitals
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tenders

U.K. Breast Cancer Diagnostics Market Data Coverage Insights

Study Period 2024-2032
Base Year 2021
Unit Revenue in USD Million
Market Value in 2024 99.29 USD Million
Market Value in 2032 198.12 USD Million
CAGR (2025-2032) 11.58%
Historic Data 2016-2023
Market Segments Covered Test,Type,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): U.K., leading in terms of revenue 99.29 USD Million in 2024
    • Key Country: U.K., leading in terms of revenue with value of 99.29 USD Million in 2024.

Segments and Scope

  • U.K. Breast Cancer Diagnostics Market to 2032, By Test
    • Imaging is the largest segment in U.K. Breast Cancer Diagnostics Market to 2032 with a revenue of 40.81 USD Million in the year 2024.
    • Imaging is the Fastest growing segment in U.K. Breast Cancer Diagnostics Market to 2032 with a Growth rate of 12.78 % in forecast period 2025-2032.
  • U.K. Breast Cancer Diagnostics Market to 2032, By Type
    • Invasive Ductal Carcinoma is the largest segment in U.K. Breast Cancer Diagnostics Market to 2032 with a revenue of 68.03 USD Million in the year 2024.
    • Invasive Ductal Carcinoma is the Fastest growing segment in U.K. Breast Cancer Diagnostics Market to 2032 with a Growth rate of 12.06 % in forecast period 2025-2032.
  • U.K. Breast Cancer Diagnostics Market to 2032, By End User
    • Hospitals is the largest segment in U.K. Breast Cancer Diagnostics Market to 2032 with a revenue of 40.94 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in U.K. Breast Cancer Diagnostics Market to 2032 with a Growth rate of 13.17 % in forecast period 2025-2032.
  • U.K. Breast Cancer Diagnostics Market to 2032, By Distribution Channel
    • Direct Tenders is the largest segment in U.K. Breast Cancer Diagnostics Market to 2032 with a revenue of 62.68 USD Million in the year 2024.
    • Direct Tenders is the Fastest growing segment in U.K. Breast Cancer Diagnostics Market to 2032 with a Growth rate of 12.16 % in forecast period 2025-2032.

U.K. Breast Cancer Diagnostics Market Company Share Analysis

 
Company Name Company Share Analysis
Koninklijke Philips N.V.
Abbott
Hologic, Inc.
Exact Sciences Corporation
F. Hoffmann-La Roche Ltd.
U.K. Breast Cancer Diagnostics Market Company Share Analysis

U.K. Breast Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Breast Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million

U.K. Breast Cancer Diagnostics Market Company Profiling

U.K. Breast Cancer Diagnostics Market Company Profiling

Industry Related Reports

South America Hospital Furniture Market
Middle East & Africa Hospital Furniture Market
North America Hospital Furniture Market
Europe Hospital Furniture Market
Asia-Pacific Hospital Furniture Market
Argentina Hospital Furniture Market
Australia Hospital Furniture Market
Belgium Hospital Furniture Market
Brazil Hospital Furniture Market
Canada Hospital Furniture Market
Frequently Asked Questions
The U.K. Breast Cancer Diagnostics Market is segmented based on Segmentation Test,Type,End User,Distribution Channel.
U.K. Breast Cancer Diagnostics Market was valued at USD 99.29(Revenue in USD Million) in 2021.
U.K. Breast Cancer Diagnostics Market is projected to grow at a CAGR of 11.58% during the forecast period of 2024 to 2032.
The Invasive Ductal Carcinoma segment is expected to dominate the U.K. Breast Cancer Diagnostics Market, holding a largest market share of 68.03 USD Million in 2024

U.K. Breast Cancer Diagnostics Market Scope

U.K. Breast Cancer Diagnostics Market Segmentation & Scope
Test
  • Others
  • Blood Test
  • Genomic Test
  • Biopsy
  • Imaging
Type
  • Metastatic Breast Cancer
  • Inflammatory Breast Cancer
  • Ductal Carcinoma In Situ
  • Invasive Ductal Carcinoma
End User
  • Others
  • Research & Academic Institutes
  • Clinics
  • Diagnostic Centers
  • Hospitals
Distribution Channel
  • Others
  • Retail Sales
  • Direct Tenders
Frequently Asked Questions
The U.K. Breast Cancer Diagnostics Market is segmented based on Segmentation Test,Type,End User,Distribution Channel.
U.K. Breast Cancer Diagnostics Market was valued at USD 99.29(Revenue in USD Million) in 2021.
U.K. Breast Cancer Diagnostics Market is projected to grow at a CAGR of 11.58% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Breast Cancer Diagnostics Market for final year is USD 198.12 (USD Million).

U.K. Breast Cancer Diagnostics Market Company Profiling

U.K. Breast Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.K. Breast Cancer Diagnostics Market is segmented based on Segmentation Test,Type,End User,Distribution Channel.
U.K. Breast Cancer Diagnostics Market was valued at USD 99.29(Revenue in USD Million) in 2021.
U.K. Breast Cancer Diagnostics Market is projected to grow at a CAGR of 11.58% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Breast Cancer Diagnostics Market for final year is USD 198.12 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES